Důkazem vysokého vzdělání je schopnost mluvit o největších věcech nejjednodušším způsobem.
David Hume
Over the past decade, magnetism and magnets have found a growing field of application in the areas of biotechnology and medical technology. Combining the forces of magnetism with micro- and nanotechnology has further miniaturized the modes of application [1]. Examples of applications are ranging from magnetoresistive-based biosensors, visualization of common biological events, to nanomedicine [2-4].
Maghemite (?-Fe2O3) is iron oxide, able to form particles smaller than 10 nm showing superparamagnetic and paramagnetic properties at room temperature [5]. The possibilities of iron oxide nanoparticles have markedly increased due to the versatile characteristics of these materials arising from the ability to manipulate and control their surface functionalities, and thus to form potentially novel material with wide range of applications. One big advantage of iron oxide nanoparticles is their biocompatibility and low toxicity vertebrates [6, 7], predestining nanomaghemite to enhance the theranostic possibilities. Within the medical field, nanomaghemite has been studied widely to enhance cancer treatment, and diagnostic techniques, such as drug delivery systems [8-10], photoabsorbers in photodynamic therapies [11, 12], hyperthermia in cancer therapies [13-15], and magnetic resonance imaging (MRI) contrast agent carriers [16-18].
Nanoparticles like maghemite, as well as carbon nanotubes, and others lack fluorescent properties sufficient to monitor their optical transport in vitro or in vivo, limiting the study of their transport [19]. Even though gadolinium has been used to enhance contrast of iron oxide nanoparticles by Kim and colleagues, and they demonstrated the potential of iron oxide nanoparticles as T1 MRI contrast agents in clinical settings [20], only few attempts have been made to optically track nanomaghemite interaction in eukaryotic cells [21, 22].
Employment of quantum dots as labels offers numerous advantages, as they are resistant to both photo- and chemical degradation over time, and they provide a wide excitation band with a narrow emission band [23]. Furthermore they exhibit pronounced brightness compared to other fluorophores. A lot of studies have been aimed at determination of both in vitro and in vivo toxicity of these nanoparticles and the results are promising to use these nanomaterials in vivo. There was shown that QDs toxicity is highly dependent on QDs crystal size, stability in solution, as well as physical environment [24-26], however, the using of properly prepared and modified QDs had negligible toxicity. Moreover, these particles can be conjugated to other materials as they were successfully conjugated to maghemite nanoparticles through covalent binding [27], or using binders like 3- aminopropyltrimethoxysilane (APTES) [28]. Generally, in core-shell QDs such as ZnSe/CdS or CdTe/CdS the shell material is grown onto the core material to reduce the nonradiative recombination effectively by confining the wave function of an electron-hole pair to the interior of core material [29, 30]. Such core-shell particles display efficient luminescence with stability superior to single phase nanoparticles and organic dyes and are of great interest for biological imaging and light-emitting devices [31].
The aim of this study was to synthesize and characterize the nanoconjugate of maghemite nanoparticles conjugated to CdTe/CdS QDs stabilized with glutathione (GSH), whose could be subsequently applied on the human embryonic kidney 293 cell culture (HEK-293) to monitor the possible interactions between luminescent nanomaghemite and eukaryotic cells. We hypothesized that thiol groups contained in glutathione may provide interaction with cell membranes, and thereby to functionalize maghemite nanoparticles to be able to serve as a tool for transport of drugs targeting the structures on outer surface of the cell membranes. Moreover; the adsorption of cells on surface of conjugate can be utilized for separation of cells from medium.
Práce je spojená s projektem CEITEC CZ.1.05/1.1.00/02.0068.
26— 2014
25— 2014
24— 2014
23— 2014
22— 2014
21— 2014
20— 2014
19— 2014
18— 2014
17— 2014
16— 2014
15— 2014
14— 2014
13— 2014
12— 2014
11— 2014
10— 2014
9— 2014
8— 2014
7— 2014
6— 2014
5— 2014
4— 2014
3— 2014
2— 2014
1— 2014
42— 2013
41— 2013
40— 2013
39— 2013
38— 2013
37— 2013
36— 2013
35— 2013
34— 2013
33— 2013
32— 2013
31— 2013
30— 2013
29— 2013
28— 2013
27— 2013
26— 2013
25— 2013
24— 2013
23— 2013
22— 2013
21— 2013
20— 2013
19— 2013
18— 2013
17— 2013
16— 2013
15— 2013
14— 2013
![]() | Zemědělská 1/1665 613 00 Brno Budova D | Tel.: +420 545 133 350 Fax.: +420 545 212 044 | ![]() |
![]() |